CT3 CAR T cells regressed tumors in 100% of mice, while continued tumor growth led to the death of all of the mice in the mock group by the end of the experiment (7 weeks after CAR T cell infusion) (Figures 6H and 6I). This evidence concerns the gene CAGE1 and neoplasm.